See more of this new facility dedicated to our leading patient access services in the above video. To learn more about our services, visit here or get in touch here.
April 24, 20254 min read
UBC Named a Pharmacovigilance Leader in Everest Group PV Operations PEAK Matrix Assessment 2025
UBC has been recognized by Everest Group as a leader in its 2025 Pre-approval Pharmacovigilance (PV) PEAK Matrix®, and a major contender in the Post-approval category. The recognition highlights UBC’s strength in delivering innovative, compliant, and patient-focused PV solutions across the drug development lifecycle.